Puma Biotechnology

We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Type
Public
HQ
Los Angeles, US
Founded
2010
Employees
156 (est)
Puma Biotechnology was founded in 2010 and is headquartered in Los Angeles, US

Key People at Puma Biotechnology

Alan H. Auerbach

Alan H. Auerbach

Chief Executive Officer, President
Troy Wilson

Troy Wilson

Director

Puma Biotechnology Locations

Los Angeles, US
South San Francisco, US
San Francisco, US

Puma Biotechnology Metrics

Puma Biotechnology Summary

Market capitalization

$1.61 B

Closing share price

$43.3
Puma Biotechnology's current market capitalization is $1.61 B.

Puma Biotechnology Market Value History

Puma Biotechnology News

Puma Biotechnology Company Life